August 18, 2021 -- Astellas Venture Management, a wholly owned subsidiary of Astellas Pharma, and LabCentral are collaborating to launch the Future Innovator Prize, formerly known as the Astellas Golden Ticket Competition.
The Future Innovator Prize offers entrepreneurial scientists and emerging biotechnology startups one-year usage of LabCentral's laboratory facilities in Cambridge, MA, as well as access to Astellas' R&D capabilities and business leaders. The prize will be awarded to two pioneering scientists with innovative research that complements Astellas' areas of interests, including oncology, immunology, and neuroscience.
Astellas Venture Management became a gold-level sponsor of LabCentral in 2019. LabCentral is a private nonprofit founded in 2013 as a launchpad for high-potential life sciences and biotech startups. The organization operates a 100,000-sq-ft facility in Cambridge, MA, where it houses lab and office space for up to 70 startups comprising approximately 500 scientists and entrepreneurs.
Applications can be submitted beginning August 18, 2021, and ending on September 20, 2021.
Copyright © 2021 scienceboard.net